ECT-CHLORPROMAZINE COMBINATION COMPARED WITH CHLORPROMAZINE ONLY IN SCHIZOPHRENIA1 by Janakiramaiah, N. & Subbakrishan, D. K.
fndian J. Psyckiat., (1981), 23(3), 230—233 
ECT-CHLORPROMAZINE COMBINATION COMPARED WITH CHLORPRO-
MAZINE ONLY IN SCHIZOPHRENIA
1 
N. JANAKIRAMAIAH
2, M.D., D.P.H., D.P.M. 
D. K. SUBBAKRISHNA", M.Sc 
SUMMARY 
Forty-four hospitalized schizophrenic patients, 22 in each of two groups, were treated for a period of 
6 weeks with either EGT-GPZ combination or CPZ alone. Ratings on RP scale (Rockland and Pollin, 1S65) 
showed that the KGT-receiving group was significantly better en several measure at second week and also had 
an earlier onset of beneficial response on "Affect and Mood." However, at the end of 6 weeks, these differences 
disappeared and on clinical Global Impression of Improvement the two groups did not differ significantly. The 
implications are disscussed. 
The role of E.C.T. in Schizophrenia 
remains ambiguous with both the advocates 
and the opponents basing their arguments 
more on personal opinion than on research 
evidence. With the advent of Chlorpro-
mazine and other neuroleptic drugs, E.C.T. 
as a treatment in Schizophrenia was super-
seded. May (1968) demonstrated that 
ECT given alone, though more effective 
than milieu therapy or psychotherapy alone, 
was considerably less effective than either 
drug therapy or drugs plus psychotherapy. 
Unfortunately, May C1968) has not addressed 
himself to the more pertinent question of 
the superiority of E.C.T.-drug combination 
over drug alone. It is now clear that for 
acutely disturbed, hospitalized schizo-
phrenics the most effective single treatment 
is by drugs. But whether adding ECT 
to drugs is beneficial is not clear. Klein 
& Davis (1969) advise ECT if there is lack 
of response to psychotropic drugs after 
6 weeks. Such a course would be inadvisable 
if ECT and drugs act synergistically. 
Sargent & Slater (1963) held that ECT 
should be given concurrently with drugs 
from the beginning. A significant practical 
question is whether such a combination 
yields better results. Is the treatment res-
ponse better and/or more rapid? It is 
surprising that so important a question as 
this received scant research attention in 
recent years. 
The present study aimed at determining 
whether there is a difference in treatment 
response between schizophrenic patients 
treated with ECT concurrently with chlor-
promazine and those treated with chlor-
promazine only. 
MATERIAL AND METHODS 
Fifty patients, diagnosed as having a 
schizophrenic psychosis according to the 
Glossary of Mental Disorders and Guide 
to their Classification (W.H.O. 1974) formed 
the sample for the present study. The 
patients were assessed thoroughly 
clinically to exclude organic brain disease, 
alcohol and drug abuse. Further, as a 
safeguard against non-schizophrenics or 
Schizophrenics getting included in the study 
a minimum duration of 6 months of illness 
was mandatory. They had to be psychotic 
at the time of inclusion. Patients with 
marked affective component who may be 
considered "schizo-affective" were parti-
cularly excluded. These were selected nearly 
consecutively, on a catch-as-catch-can basis, 
within two or three days after their admission 
into the psychiatric wards of National In-
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stitute of Mental Health and Neuro Sciences, 
Bangalore. Patients were of both sexes 
(32 male and 18 female) between 15 and 
45 years (mean age = 29.2 years) and with 
the total duration of illness ranging from 
6 months to 2 years. 
Patients admitted to the study were 
randomly allocated to one of the two treat-
ments : 300 mg/day Chlorpromazine plus 
ECT twice a week for the study period of 
6 weeks. Direct ECT was given to all 
those who had to receive it, but on a few 
occasions, in some patients, it was missed. 
In no patient, however, was the number of 
treatments less than eight, and 16 patient? 
received the planned course of 12 treat-
ments. No other physical methods of treat-
ment were given except parentral Paral-
dehyde to patients with uncontrollable be-
haviour. 
Assessment : The psychiatric condition 
of the patients was assessed on RP scale 
(Rockland and Pollin, 1965), which is a 
symptom rating scale for use with psychotic 
patients. It has 16 items, the first ten of 
them bipolar, and was shown to give a 
reliable and valid measure of the "Psycho-
ticness" of Schizophrenic patients. Assess-
ments on this scale were done initially 
and at first, second, fourth, and sixth weeks. 
Clinical Global Impression of improvement 
at 6th week was also noted on a 7 point 
scale (0-6, higher score indicating better 
improvement). The person making the 
assessments (N. J.) remained blind to the 
patient's treatment. 
To determine the significance of the 
differences between the two treatment groups 
with respect to changes in the RP Scale 
scores from occasion to occasion, relative 
to initial scores, analysis of covariance— 
one way classification was used. Secondly, 
the significance of changes within each of 
the two groups, compared to the initial 
scores was determined by a Paired "t" 
test. Finally, for the difference on the mean 
CGI scores Student's 't' test to test the 
equality of 2 means was used. 
RESULTS 
Whole scale positive scores (measuring 
hyperactive, talkative and acting out be-
haviour) and whole scale negative scores 
(measuring the inactive, withdrawn and 
depressed behaviour) on the R. P. Scale 
were considered separately. Differences 
between the two groups with respect to 
change on the whole scale positive scores 
at first week, fourth week, and sixth week 
relative to the initial score were not signi-
ficant. Changes on the whole scale negative 
scores followed the same pattern. Differ-
ences between the two groups on whole 
scale positive and whole scale negative 
scores at second week are shown in Table 1. 
TABLE 1—Differences between the two treatment 
groups on whole scale positive and negative 
scores initially and at 2nd week 
Variable Initial 2nd Week Corrected 
mean mean mean 
W. S. Positive Score: 
300mg+ECT 27.45 10.14 10.20 
300 rag only 27.82 19.18 19.12 
F=64.1 ; d.f. = l,40; p<0.01 
W. S. Negative Score: 
300mg+ECT 13.45 4.86 4.75 
300 mg only 12.95 11.31 11.43 
F=48.59; d.f. = l,40; p<0.01 
Changes on the category scores of 
"content of Thought and thought Process" 
were significantly different between the 
groups only at second week (F=60.82, 
d.f. = l, 40, p<.01). Both the positive and 
the negative subscores on "General Appear-
ance and Manner" changed significantly 
differently between the groups at the fourth 
as well as at the second week (Table 2). 
All the significant differences were in favour 
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TABLE 2—Difference betewen the 2 treatment groups on "General Appearance" 
Variable 
Positive Score: 
300 mg + ECT 
300 mg only 
Negative Score: 
300 mg + ECT 
300 mg only 
F= 
F= 
Initial 
mean 
8.72 
9.09 
=32.09; d.f. 
9.50 
9.04 
= 35.33; d.f.= 
Ilnd Week 
mean 
2.54 
6.50 
= 1,40; p<0.05 
3.23 
7.77 
= 1,40; p<0.01 
Corrected 
mean 
2.62 
6.43 
3.15 
7.85 
4th Week 
mean 
1.32 
2.50 
F=4.65; 
1.68 
2.77 
F=4.22; 
d.f.= 
d.f.= 
Corrected 
mean 
1.34 
2.48 
= 1,40; p<0.05 
1.64 
2.73 
= 1,40; p<0.05 
Differences between the groups on 
"Affect and Mood" scores were not sig-
nificant at any time except at the second 
week on negative score (F= 17.89; df= 
1,40, P<.01) and at the fourth week on 
positive score (F=9.59; d.f. = l,40, p<.05) 
when the CPZ+ECT group was better. 
Changes on "Affect and Mood" from the 
initial scores through 2nd, 4th, and 6th 
weeks within groups (Paired 't' test, df= 
21) are shown in Table 3. 
Changes on both positive and negative 
scores on "General Appearance and 
Manner" as well as on the "Content of 
Thought and Thought Process" scores over 
time relative to the initial scores within 
the groups were significant from the first 
week itself in both the treatment groups. 
Hence no difference in the onset of bene-
ficial response could be seen between the 
two treatment groups, in contrast to what 
is obtained on "Affect and Mood." The 
only exception to this was, however, with 
respect to the negative score on "General 
Appearance and Manner" at first week. 
The difference between the initial and 
first week scores was significant (t=3.51, 
p<.01) in the group receiving 300 mg 
of CPZ plus ECT whereas it was 
not so in the other group (t=0.75, not 
significant). 
The mean difference between the groups 
TABLE 3—Changes on "Affect and Mood''' from the Initial scores within groups over time 
Variable 
Positive : 
300 m<,' f ECT 
300 mg only 
Negative: 
300mg+ECT 
300 mg only 
Initial Vs. 
1st wk. 
t 
2.66 
0.39 
0.46 
0.52 
P 
<.05 
N. S. 
N. S. 
N. S. 
Initial Vs. 
2nd 
t 
7.23 
3.28 
5.84 
1.03 
wk. 
P 
<0.01 
<.01 
<.01 
N. S. 
Initial Vs. 
4th 
t 
7.84 
5.69 
9.30 
7.75 
wk. 
P 
<.01 
<.001 
<0.01 
<0.01 
Initial Vs. 
6th wk. 
t 
7.38 
4.86 
10.43 
7.28 
P 
<0.0I 
<0.001 
< .01 
< .01 
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on clinical Global Impression of improve-
ment at 6th week is not significant (t= 
0.3, d.f.=42, p>.05). 
COMMENT 
The findings of the present study are 
in partial agreement with the commonly 
held clinical opinion that addition of ECT 
to CPZ yields a better tretament response. 
ECT receiving group was significantly better 
at second week on several components of 
psychosis than the group without ECT. 
Secondly, "Affect and Mood" component 
improved significantly earlier with ECT. 
This selective effect holds at least a partial 
explanation for the efficacy of ECT in 
the treatment ot Schizophrenia, in view of 
the evidence that ECT is rapidly effective 
against depression. Corroborating with this 
is the absence of any significant difference 
between the two groups at 6 weeks. When 
the time necessary for the CPZ to exert 
its full beneficial effect is allowed ECT has 
no specific anti-schizophrenic effect. 
That the superior response with ECT-
CPZ combination observed early in the 
course of treatment flattens out to the level 
of response with CPZ alone at 6 weeks 
tallies with the report by Smith et al. 
(1967). However, in view of the single 
level of CPZ in the present study as well 
as in that by Smith et al. (1967) it is not 
known what effect ECT has at different 
levels of CPZ. Cole and Davis (1969) 
v analysed the efficacy of CPZ as compared 
to that of placebo, using controlled studies, 
and noted that studies which utilized a 
very low dose level (400 mg/day or less) 
obtained equivocal results. They recom-
mended that to obtain a better than placebo 
response for a set of patients as a group 
the CPZ dosage must be at least 500 mg/ 
day. It is probable that the 300 mg/day 
of CPZ in the present study is on the low 
side and the observed superiority of the 
addition of ECT is a reflection of its effect 
on an inadequately treated group of patients. 
A study of ECT in combination with differ-
ent levels of CPZ in Schizophrenia is advised 
towards a clarification of this issue. 
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